Pan-European patent court delivers first revocation judgment a year and a month after opening | 4d
Pan-European patent court delivers first revocation judgment a year and a month after opening | 4d
Trio of partners join from Wilson Sonsini and boutique Hooper Lundy & Bookman as Orrick continues life sciences push | 1w
Raleigh office will target healthcare work and is top 50 firm’s 23rd US base | 1w
Glucose monitoring patent revoked across 17 UPC member states in ongoing dispute with rival Abbott | 1w
This first edition, written by leading AI legal specialists, provides answers and insight on how to integrate Artificial Intelligence into business operations, whilst working within the relevant law and guidelines in key jurisdictions around the world. | 1yr
Editor:
Freshfields, Taylor Wessing and Powell Gilbert advise on closely watched London High Court dispute | 2w
IP and disputes group’s move follows ArentFox Schiff adding automotive partner quartet from Burns in Boston in April | 1mo
Team moves over from Lerner David strengthening medical device practice | 1mo
Decision upholds earlier ruling revoking patent covering the drug Xarelto, further clearing way for generic manufacturers to enter the lucrative market | 1mo
Tobias Knapp joins as co-head of global firm’s New York transactional group | 1mo
Covington counsels Biogen as Goodwin reps acquisition target Human Immunobiology Biosciences | 1mo
Former FDA lawyers Jennifer Bragg and William McConagha move over in DC as Safehold CLO Douglas Heitner joins real estate team in New York | 2mos
Office to handle outbound work for Japanese clients as UK firm aims to reach €1bn revenue in five years | 2mos
Led by respected life sciences litigator Siegmund Gutman, the team of 10 move over from Proskauer Rose | 2mos
Düsseldorf local division orders US life sciences company Curio Bioscience to stop selling its products in Germany, France and Sweden in dispute with rival 10x Genomics | 2mos
Transatlantic merger creates global giant with nearly 4,000 lawyers and $3.5bn revenue | 2mos
UK pharmaceutical firm enters the fray in the battle over mRNA technology used to develop blockbuster vaccines | 2mos
Greenberg counsels Ono in deal to expand Japanese group’s oncology portfolio and US presence | 2mos
Women make up majority of round for firm in strong growth mode | 2mos
Irena Royzman is fourth IP partner to join tech-focused firm this year | 3mos
John Godfrey is the 12th Paul Weiss lawyer to decamp to Sidley in past 10 months | 3mos